EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 11-Jul-2025 20:10 ET (12-Jul-2025 00:10 GMT/UTC)

Argobio and the Institut Pasteur launch Enodia Therapeutics: A biotech company with a new approach for targeted protein degradation

Institut Pasteur
Business Announcement

Turning groundbreaking research from the Institut Pasteur with the support of Argobio’s start-up studio, into novel treatments for cancer, inflammatory diseases and viral infections. The platform leverages state-of-the-art generative artificial intelligence (AI) to design selective inhibitors of the Sec61/translocon molecular complex for blocking and degrading disease-causing proteins. Enodia Therapeutics is the winner of Pfizer sponsor BioLabs Paris Hotel Dieu coveted 2025 Golden Ticket competition.

Interventions identified to eliminate transmission of hepatitis B in Africa

University of Liverpool
Peer-Reviewed Publication

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers at the University of Liverpool and Liverpool School of Tropical Medicine conducted analysis revealing key interventions that could effectively eliminate vertical transmission of chronic hepatitis B, one of the leading causes of liver cancer and cirrhosis in the region.

Journal: The Lancet Global Health

Decoding the link between colorectal cancer risk and steatotic liver disease

Shinshu University
Peer-Reviewed Publication

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has emerged as a heterogenous disease tightly linked to metabolic dysfunction and has been redefined under the umbrella term ‘steatotic liver disease’ (SLD). However, CRC risk variations across different SLD subgroups remain unknown. Now, researchers from Japan have discovered that the risk of CRC varies significantly among SLD subgroups, with patients with alcoholic liver disease being at higher risk.

Journal: Clinical Gastroenterology and Hepatology
Funder: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare of Japan, NIH/National Center for Advancing Translational Sciences (NCATS), National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute, John C. Martin Foundation

Why brain cancer is often resistant to immunotherapy

Broad Institute of MIT and Harvard
Peer-Reviewed Publication

New findings from researchers at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common and aggressive type of primary brain cancer. In Nature, the researchers describe four gene expression “programs” — sets of genes with coordinated activity — that either suppress the immune system or make it more active. Defining and understanding what drives these programs could one day help researchers target them with new drugs to dial up or down specific parts of the immune system to improve patient response to immunotherapy.

Journal: Nature

Innovative CT scan technique could improve prognosis and treatments for head and neck cancers, new research suggests

University of Maryland School of Medicine
Peer-Reviewed Publication

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year with one in five cases occurring in people younger than 55, according to the American Cancer Society. A new study provides insights that may eventually help oncologists better predict how the disease will respond to certain therapies, leading to improved survival outcomes for patients.

Journal: Scientific Reports
Funder: NIH/National Institutes of Health, NIH/National Institutes of Health, NIH/National Institute of Dental and Craniofacial Research

Treatment strategy reprograms brain cancer cells, halting tumor growth

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones.

Journal: Proceedings of the National Academy of Sciences
Funder: NIH/National Institutes of Health, NIH/National Cancer Institute, California Institute for Regenerative Medicine, American Cancer Society

Breast-conserving surgery improves sexual well-being compared to breast reconstruction

Wolters Kluwer Health
Peer-Reviewed Publication

For women with breast cancer, breast-conserving therapy (BCT) is associated with improved sexual well-being, compared to mastectomy followed by breast reconstruction, reports a study in the March issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Journal: Plastic & Reconstructive Surgery

UC Irvine-led study finds possible links between PFAS exposure and childhood cancers

University of California - Irvine
Peer-Reviewed Publication

A study led by the Joe C. Wen School of Population & Public Health at the University of California, Irvine has revealed possible links between exposure to per- and polyfluoroalkyl substances in drinking water and an increased risk of certain childhood cancers.

Journal: Environmental Epidemiology

MD Anderson Research Highlights for February 26, 2025

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

City of Hope research features myeloma study, cancer surgery and more

City of Hope
Peer-Reviewed Publication

LOS ANGELES — City of Hope^® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment.